STC
ADVM

SEI Trust Company’s Adverum Biotechnologies ADVM Stock Holding History

SEI Trust Company’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$275K Buy
+803
New +$239K ﹤0.01% 1240

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

SEI Trust Company's ADVM Position: Q3 2014 in Review

SEI Trust Company opened a new position in Adverum Biotechnologies (ADVM) in Q3 2014: 803 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #1240 among its holdings.

58 funds tracked by Wall St. Rank hold ADVM as of Q3 2014.

  • SEI Trust Company held 803 shares of Adverum Biotechnologies worth $275K as of Q3 2014.
  • Adverum Biotechnologies was a new SEI Trust Company position in Q3 2014.
  • Adverum Biotechnologies made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1240 holding.
  • 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.